JPH10511097A - 低薬用量リドグレル調合物および炎症性腸疾患の処置のためのそれらの使用 - Google Patents

低薬用量リドグレル調合物および炎症性腸疾患の処置のためのそれらの使用

Info

Publication number
JPH10511097A
JPH10511097A JP8528894A JP52889496A JPH10511097A JP H10511097 A JPH10511097 A JP H10511097A JP 8528894 A JP8528894 A JP 8528894A JP 52889496 A JP52889496 A JP 52889496A JP H10511097 A JPH10511097 A JP H10511097A
Authority
JP
Japan
Prior art keywords
lidogrel
acid
treatment
pharmaceutically acceptable
inflammatory bowel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8528894A
Other languages
English (en)
Japanese (ja)
Inventor
ベルリンデン，マリア−ヘレナ・ジヨリス・ジヨゼフ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of JPH10511097A publication Critical patent/JPH10511097A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP8528894A 1995-03-28 1996-03-18 低薬用量リドグレル調合物および炎症性腸疾患の処置のためのそれらの使用 Pending JPH10511097A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE95200768.0 1995-03-28
EP95200768 1995-03-28
PCT/EP1996/001229 WO1996030016A2 (fr) 1995-03-28 1996-03-18 Formulations de ridogrel a petites doses et leur utilisation dans le traitement de maladies intestinales inflammatoires

Publications (1)

Publication Number Publication Date
JPH10511097A true JPH10511097A (ja) 1998-10-27

Family

ID=8220134

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8528894A Pending JPH10511097A (ja) 1995-03-28 1996-03-18 低薬用量リドグレル調合物および炎症性腸疾患の処置のためのそれらの使用

Country Status (10)

Country Link
EP (1) EP0817631A2 (fr)
JP (1) JPH10511097A (fr)
AR (1) AR002727A1 (fr)
AU (1) AU5397496A (fr)
CA (1) CA2215160A1 (fr)
HU (1) HUP9900309A3 (fr)
IL (1) IL117670A (fr)
NO (1) NO974486D0 (fr)
WO (1) WO1996030016A2 (fr)
ZA (1) ZA962461B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
EP1370244A1 (fr) * 2001-03-12 2003-12-17 Novo Nordisk A/S Nouveaux comprimes et gelules et procede de preparation correspondant
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
PT2396081T (pt) 2009-02-16 2017-07-11 Nogra Pharma Ltd Compostos alquilamido e suas utilizações
CA2864059C (fr) 2012-02-09 2020-04-28 Nogra Pharma Limited Methodes de traitement de la fibrose
BR112014026160A2 (pt) 2012-04-18 2017-07-18 Nogra Pharma Ltd métodos para tratar intolerância à lactose
WO2017046343A1 (fr) * 2015-09-17 2017-03-23 Nogra Pharma Limited Compositions pour une administration par voie rectale dans le traitement de la colite ulcéreuse et leurs procédés d'utilisation
EA202192207A1 (ru) 2019-02-08 2021-10-27 Ногра Фарма Лимитед Способ получения 3-(4'-аминофенил)-2-метоксипропионовой кислоты и ее аналогов и промежуточных соединений

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746671A (en) * 1985-11-04 1988-05-24 Janssen Pharmaceutica N.V. Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters

Also Published As

Publication number Publication date
EP0817631A2 (fr) 1998-01-14
ZA962461B (en) 1997-09-29
WO1996030016A2 (fr) 1996-10-03
IL117670A (en) 2000-02-29
HUP9900309A2 (hu) 1999-05-28
CA2215160A1 (fr) 1996-10-03
WO1996030016A3 (fr) 1997-01-30
NO974486L (no) 1997-09-29
AR002727A1 (es) 1998-04-29
NO974486D0 (no) 1997-09-29
AU5397496A (en) 1996-10-16
HUP9900309A3 (en) 1999-11-29
IL117670A0 (en) 1996-07-23
MX9707394A (es) 1997-11-29

Similar Documents

Publication Publication Date Title
KR100664479B1 (ko) 발데콕시브 조성물
US4753789A (en) Method for treating nausea and vomiting
SK147796A3 (en) Pharmaceutical formulation and its use
HUT77391A (hu) A droloxifen alkalmazása keringési megbetegedésekben
JPH10508866A (ja) オンダンセトロンを含有する経口組成物
JP2005506987A (ja) 感覚的に許容される口内崩壊性組成物
KR20180019173A (ko) 과한 체중으로 영향 받은 여성 환자를 위한 드로스피레논-기반의 피임제
WO2011026080A1 (fr) Compositions à désintégration rapide de méloxicame, procédés pour sa fabrication et utilisation pour traiter l'arthrite et/ou la douleur
EA027641B1 (ru) Продукт сомикронизации, включающий ацетат улипристала
Ali et al. Belumosudil with ROCK-2 inhibition: chemical and therapeutic development to FDA approval for the treatment of chronic graft-versus-host disease
JPH10511097A (ja) 低薬用量リドグレル調合物および炎症性腸疾患の処置のためのそれらの使用
WO2005034936A1 (fr) Utilisation de l-butylphtalide dans la fabrication de medicaments destines a la prevention et au traitement de l'infarctus cerebral
KR100681360B1 (ko) 타액분비 촉진용 카르보스티릴 유도체
JP2000502345A (ja) 鬱病の処置方法
US20060063747A1 (en) Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or derivative thereof
JP7399502B2 (ja) びらん性変形性手関節症の治療のためのモンテルカスト
EA007952B1 (ru) Применение ирбесартана для изготовления лекарств, которые пригодны для предупреждения или лечения лёгочной артериальной гипертензии
KR20020062285A (ko) 자궁내막염 혹은 불임의 치료 혹은 임신력 향상 방법
JP2834175B2 (ja) 医 薬
WO2008148359A1 (fr) Utilisations thérapeutiques de dérivés d'acide imidazol-5-carboxylique
TW202336015A (zh) 唑－４－羧酸結晶之製備方法及包含彼之醫藥組成物
US10485808B2 (en) Selective progesterone receptor modulators (SPRM) and stabilized estrogen level in patient
JP2001510155A (ja) 選択的セロトニン再摂取阻害剤を用いる心臓障害の治療および予防
TW200418462A (en) 2'-halo-3'-5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug
JP2000502346A (ja) 皮膚炎の処置方法